SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-004143
Filing Date
2014-12-15
Accepted
2014-12-15 08:04:07
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 682354
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15883
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 15849
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5665
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5649
  Complete submission text file 0001493152-14-004143.txt   6039755

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE corx-20130630.xml EX-101.INS 613315
7 XBRL SCHEMA FILE corx-20130630.xsd EX-101.SCH 64906
8 XBRL CALCULATION FILE corx-20130630_cal.xml EX-101.CAL 50653
9 XBRL DEFINITION FILE corx-20130630_def.xml EX-101.DEF 268344
10 XBRL LABEL FILE corx-20130630_lab.xml EX-101.LAB 452078
11 XBRL PRESENTATION FILE corx-20130630_pre.xml EX-101.PRE 322940
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 141285110
SIC: 2834 Pharmaceutical Preparations